Cargando…
Neuronal antibodies in adult patients with new‐onset seizures: A prospective study
OBJECTIVES: Immunotherapy in addition to antiepileptic drugs can improve seizure freedom rates in autoimmune epilepsy, highlighting the importance of early diagnosis. A diagnosis of autoimmune epilepsy can be supported by presence of serum antibodies to neuronal antigens. We asked how often neuronal...
Autores principales: | Zelano, Johan, Axelsson, Markus, Constantinescu, Radu, Malmeström, Clas, Kumlien, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851805/ https://www.ncbi.nlm.nih.gov/pubmed/31588654 http://dx.doi.org/10.1002/brb3.1442 |
Ejemplares similares
-
The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective survey
por: Sandgren, Sofia, et al.
Publicado: (2023) -
Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers
por: Novakova, Lenka, et al.
Publicado: (2018) -
A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis
por: Sandgren, Sofia, et al.
Publicado: (2023) -
Recurrence risk after a first remote symptomatic seizure in adults: Epilepsy or not?
por: Zelano, Johan
Publicado: (2021) -
CSF orexin-A levels after rituximab treatment in recent onset narcolepsy type 1
por: Wasling, Pontus, et al.
Publicado: (2019)